Full Press Release Details
CRISPR Therapeutics Raises $25 million in Series A Financing and Announces Founding Team of World-Renowned Academics and Clinicians.
CRSP
CRISPR Therapeutics Raises $25 million in Series A Financing and Announces Founding Team of World-Renowned Academics and Clinicians
Key Takeaway: CRISPR Therapeutics Raises $25 million in Series A Financing and Announces Founding Team of World-Renowned Academics and Clinicians
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension